Synthesis of thiolated chitosan. Thiolated chitosan was synthesized by modifying the previously reported method. 1 Chitosan (medium molecular weight) solution was prepared by dissolving 200 mg chitosan in 20 mL of 1% (v/v) acetic acid solution to which 160 µL of thioglycolic acid was added. Then, 0.2 g of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride was added to the solution so as to activate the carboxylic acid moieties of TGA. The pH of the whole solution was adjusted to 5.0 using 5 mol/L of NaOH solution. The solution was stirred for 6 h at room temperature. The obtained thiolated chitosan was purified through ultra-filtration (molecular weight cut-off 30 kDa, Millipore) followed by lyophilization. The final product was stored at -20 °C.
disulfate salt (200 µg/mL) (Sigma), penicillin (100 U/mL), streptomycin (100 µg/mL) and 10% FBS. The EMT6-OVA cells were characterized by Western blotting analysis of OVA expression. Primary antibodies: mouse anti-OVA polyclonal antibody (Thermo Scientific) at a dilution of 1:1000 and mouse anti-GAPDH monoclonal antibody (Sigma-Aldrich) at a dilution of 1:5000. Secondary antibody:
IRDye680 goat anti-mouse IgG (Li-Cor) at a dilution of 1:10,000. After washing, the fluorescence in the membrane was visualized under an Odyssey imaging system (Li-Cor).
Flow cytometric analysis of intracellular IFN-γ production by CD8 + T cells in tumor.
EMT6-OVA tumor-bearing mice were used to assess the antigen-specific T cell response. Briefly Flow cytometric analysis of intracellular IFN-γ production by CD8 + T cells in tumor following OVA (5 µg/mL) stimulation in vitro at Day 12.
